CME Group Inc.

CME Financial Financial Data & Stock Exchanges

CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 2.85%, free cash flow fell 11.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

293.87 4.41 +1.52%
Market cap
$104.1B
P/E
24.7×
Fwd P/E
21.7×
Dividend yield
1.31%
F-score
4/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

CME Group Inc. (CME) EBITDA

Alert me on EBITDA

CME Group Inc.'s EBITDA for fiscal 2025 was $4.6B, up 6.84% from $4.3B in fiscal 2024. Over the twelve months to 30 June 2026 it was $4.7B. Over the past ten years it has ranged from $2.2B (fiscal 2015) to $4.6B (fiscal 2025) — the current reading is the highest in ten years. EBITDA has risen for 4 consecutive fiscal years. CME Group Inc. ranks 3rd of 15 Financial Data & Stock Exchanges companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $4.6B 6.84%
FY2024 $4.3B 12.67%
FY2023 $3.8B 12.13%
FY2022 $3.4B 11.48%
FY2021 $3.0B (2.30%)
FY2020 $3.1B 1.33%
FY2019 $3.1B 7.17%
FY2018 $2.9B 13.39%
FY2017 $2.5B 3.85%
FY2016 $2.4B 9.40%

Quarterly newest first

Period EBITDA Change
Jun 2026 $1.2B (14.48%)
Mar 2026 $1.4B 26.41%
Dec 2025 $1.1B 4.44%
Sep 2025 $1.1B (12.99%)
42 more quarters

Against its own ten years

Low $2.2B High $4.6B
Ten-year median $3.1B
Current reading's percentile 100

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on CME